Mural Oncology (NASDAQ:MURA) Stock Price Down 1.1%

Shares of Mural Oncology plc (NASDAQ:MURAGet Free Report) fell 1.1% during mid-day trading on Wednesday . The company traded as low as $4.36 and last traded at $4.39. 373,744 shares changed hands during mid-day trading, an increase of 20% from the average session volume of 312,184 shares. The stock had previously closed at $4.44.

Mural Oncology Stock Down 1.1 %

The firm’s 50 day moving average price is $4.46.

Mural Oncology (NASDAQ:MURAGet Free Report) last issued its quarterly earnings data on Thursday, December 14th. The company reported ($3.07) earnings per share for the quarter.

Mural Oncology Company Profile

(Get Free Report)

Mural Oncology Plc, a clinical-stage oncology company, focuses on discovering and developing immunotherapies for the treatment of patients with cancer. The company's lead product candidate includes nemvaleukin alfa for the treatment of mucosal melanoma as a monotherapy and platinum-resistant ovarian cancer in combination with pembrolizumab.

Read More

Receive News & Ratings for Mural Oncology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mural Oncology and related companies with MarketBeat.com's FREE daily email newsletter.